A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma

Author： Peterson Amy   Harlin Helena   Karrison Theodore   Vogelzang Nicholas   Knost James   Kugler John   Lester Eric   Vokes Everett   Gajewski Thomas   Stadler Walter  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.24, Iss.2, 2006-03, pp. : 141-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I trial of thalidomide and Interleukin-2 in patients with metastatic renal cell carcinoma

By Olencki Thomas   Malhi Sareena   Mekhail Tarek   Dreicer Robert   Elson Paul   Wood Laura   Bukowski Ronald  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 321-326

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study

By Morgan Robert  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 723-728

Springer Publishing Company

Access to resources Recommend Favorite

A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study

By Armstrong Deborah K.   Blessing John A.   Rader Janet   Sorosky Joel I.  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 453-457

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of imatinib (Gleevec®) in patients with metastatic renal cell carcinoma

By Vuky Jacqueline   Isacson Christina   Fotoohi Mehran   Cruz Jason   Otero Henry   Picozzi Vincent   Malpass Thomas   Aboulafia David   Jacobs Andrew  

Investigational New Drugs, Vol. 24, Iss. 1, 2006-01 ,pp. : 85-88

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate

By Bruce Justine  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 794-802

Springer Publishing Company

Access to resources Recommend Favorite